Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10912921rdf:typepubmed:Citationlld:pubmed
pubmed-article:10912921lifeskim:mentionsumls-concept:C0031119lld:lifeskim
pubmed-article:10912921lifeskim:mentionsumls-concept:C0005558lld:lifeskim
pubmed-article:10912921lifeskim:mentionsumls-concept:C0393819lld:lifeskim
pubmed-article:10912921lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:10912921lifeskim:mentionsumls-concept:C1328307lld:lifeskim
pubmed-article:10912921lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:10912921lifeskim:mentionsumls-concept:C0868928lld:lifeskim
pubmed-article:10912921pubmed:issue1lld:pubmed
pubmed-article:10912921pubmed:dateCreated2000-11-9lld:pubmed
pubmed-article:10912921pubmed:abstractTextThe possible occurrence of chronic inflammatory demyelinating polyneuropathy (CIDP) in association with an identified dysglobulinemic status is recognized and a causal relationship between the two has been suggested. We had the opportunity to study 18 patients presenting with CIDP and dysglobulinemia. This was an IgG monoclonal gammopathy (IgG MG) in 8 cases, an IgM monoclonal gammopathy (IgM MG) in 8, an IgG-IgM biclonal gammopathy in 1 case and an IgM monoclonal cryoglobulinemia in another. A peripheral nerve biopsy specimen was available for all patients and the morphological findings in these specimens in the cases of CIDP with IgG MG or cryoglobulin did not differ from those without, whereas characteristic features were observed in the cases of CIDP with IgM MG and anti-myelin associated glycoprotein activity.lld:pubmed
pubmed-article:10912921pubmed:languageenglld:pubmed
pubmed-article:10912921pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10912921pubmed:citationSubsetIMlld:pubmed
pubmed-article:10912921pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10912921pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10912921pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10912921pubmed:statusMEDLINElld:pubmed
pubmed-article:10912921pubmed:monthJullld:pubmed
pubmed-article:10912921pubmed:issn0001-6322lld:pubmed
pubmed-article:10912921pubmed:authorpubmed-author:HenryPPlld:pubmed
pubmed-article:10912921pubmed:authorpubmed-author:JulienJJlld:pubmed
pubmed-article:10912921pubmed:authorpubmed-author:LaguenyAAlld:pubmed
pubmed-article:10912921pubmed:authorpubmed-author:VitalCClld:pubmed
pubmed-article:10912921pubmed:authorpubmed-author:BaratMMlld:pubmed
pubmed-article:10912921pubmed:authorpubmed-author:BoisseauCClld:pubmed
pubmed-article:10912921pubmed:authorpubmed-author:StechDDlld:pubmed
pubmed-article:10912921pubmed:authorpubmed-author:VitalAAlld:pubmed
pubmed-article:10912921pubmed:authorpubmed-author:Guiraud-Chaum...lld:pubmed
pubmed-article:10912921pubmed:authorpubmed-author:FerreyGGlld:pubmed
pubmed-article:10912921pubmed:authorpubmed-author:HerbelleauTTlld:pubmed
pubmed-article:10912921pubmed:authorpubmed-author:LouisetPPlld:pubmed
pubmed-article:10912921pubmed:authorpubmed-author:HermosillaEElld:pubmed
pubmed-article:10912921pubmed:authorpubmed-author:Rouanet-Larri...lld:pubmed
pubmed-article:10912921pubmed:authorpubmed-author:BredinAAlld:pubmed
pubmed-article:10912921pubmed:issnTypePrintlld:pubmed
pubmed-article:10912921pubmed:volume100lld:pubmed
pubmed-article:10912921pubmed:ownerNLMlld:pubmed
pubmed-article:10912921pubmed:authorsCompleteYlld:pubmed
pubmed-article:10912921pubmed:pagination63-8lld:pubmed
pubmed-article:10912921pubmed:dateRevised2007-11-9lld:pubmed
pubmed-article:10912921pubmed:meshHeadingpubmed-meshheading:10912921...lld:pubmed
pubmed-article:10912921pubmed:meshHeadingpubmed-meshheading:10912921...lld:pubmed
pubmed-article:10912921pubmed:meshHeadingpubmed-meshheading:10912921...lld:pubmed
pubmed-article:10912921pubmed:meshHeadingpubmed-meshheading:10912921...lld:pubmed
pubmed-article:10912921pubmed:meshHeadingpubmed-meshheading:10912921...lld:pubmed
pubmed-article:10912921pubmed:meshHeadingpubmed-meshheading:10912921...lld:pubmed
pubmed-article:10912921pubmed:meshHeadingpubmed-meshheading:10912921...lld:pubmed
pubmed-article:10912921pubmed:meshHeadingpubmed-meshheading:10912921...lld:pubmed
pubmed-article:10912921pubmed:meshHeadingpubmed-meshheading:10912921...lld:pubmed
pubmed-article:10912921pubmed:meshHeadingpubmed-meshheading:10912921...lld:pubmed
pubmed-article:10912921pubmed:meshHeadingpubmed-meshheading:10912921...lld:pubmed
pubmed-article:10912921pubmed:meshHeadingpubmed-meshheading:10912921...lld:pubmed
pubmed-article:10912921pubmed:meshHeadingpubmed-meshheading:10912921...lld:pubmed
pubmed-article:10912921pubmed:meshHeadingpubmed-meshheading:10912921...lld:pubmed
pubmed-article:10912921pubmed:year2000lld:pubmed
pubmed-article:10912921pubmed:articleTitleChronic inflammatory demyelinating polyneuropathy associated with dysglobulinemia: a peripheral nerve biopsy study in 18 cases.lld:pubmed
pubmed-article:10912921pubmed:affiliationDepartment of Neuropathology, Victor Segalen University, Bordeaux II Cedex, France.lld:pubmed
pubmed-article:10912921pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10912921pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed